Phase I study of intratumoral administration of CF33-HNIS-antiPDL1 in patients with metastatic triple negative breast cancer.
Year: 2022
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Yuan Yuan, Jianying Zhang, Jonathan Kessler, Jamie Rand, Badri Modi, Shyambabu Chaurasiya, Mireya Murga, Aileen Tang, Norma Martinez, Hans Meisen, Dave Yamauchi, Susan Elaine Yost, Leslie Mi Ok Chong, Amanda Seiz, Bonnie Nixon, Nicholas Ede, James Ross Waisman, Daphne B. Stewart, Joanne E. Mortimer, Yuman Fong
Institution: City Of Hope National Medical Center
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4281765131